New Topical Ointment to Treat Lupus Lesions

What we are studying

The main purpose of this study is to see the effect of an ointment on active discoid lesions in people with discoid lupus erythematosus (DLE) and systemic lupus erythematosus (SLE). The study will look at changes in redness and scaling of the discoid lesions treated with the study drug. Researchers also want to find out if the ointment is safe and tolerable.

Who we are studying

• Men and Women
• Races:
  • White
  • African American
  • Asian
  • American Indian or Alaska Native
  • Native Hawaiian or Pacific Islander
  • Other
• All Ethnicities
• Ages 18 - 75

Eligibility Criteria

• Diagnosed with Systemic Lupus Erythematosus (SLE) or Discoid Lupus Erythematosus (DLE)
• 2 active SLE or DLE lesions
• Cannot have poorly controlled high blood pressure

What is involved

• 11 weeks
• 8 study visits
• Physical exam
• Health and medication questions
• Vital Signs
• Height and Weight
• Blood tests
• Urine tests
• Tracing of your heart rhythm (ECG)
• Study drug

Compensation:

Up to $480

Contact Information

Study Coordinator

Dermatology Clinical Studies

Email

dermadvertising@wakehealth.edu

Phone

336-716-3775